Adam JacksonAugust 29, 2022
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) posted results that showed healthy margins despite revenues slightly slumping over the quarter amid the company’s international bid. The pharmaceutical cannabis company announced today its financial results for the second quarter ending June 30, 2022. Khiron’s second-quarter revenues totaled $4.47 million, down 3% versus $4.6 million in […]
